Literature DB >> 8081057

Bone mass measurement for premenopausal women.

R Lindsay1.   

Abstract

Bone mass measurement is a useful tool in determining the risk of fracture. However, there are questions about whether or not bone mass measurement should be used in premenopausal women. Part of the problem concerns the issue of whether or not bone mass or bone density falls prior to menopause. Significant prospective data are still being gathered on this issue, which is hotly debated. In addition, even if there is a loss of bone density prior to menopause, it is not evident what clinical strategy would result from the measurement. At present, therefore, it seems prudent only to measure bone mass of women who have significantly impaired ovarian function or who are approaching menopause.

Entities:  

Mesh:

Year:  1994        PMID: 8081057     DOI: 10.1007/bf01623434

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  24 in total

1.  Bone mass and body composition in normal women.

Authors:  R Lindsay; F Cosman; B S Herrington; S Himmelstein
Journal:  J Bone Miner Res       Date:  1992-01       Impact factor: 6.741

2.  Compliance with hormone replacement therapy (HRT) after screening for post menopausal osteoporosis.

Authors:  P J Ryan; R Harrison; G M Blake; I Fogelman
Journal:  Br J Obstet Gynaecol       Date:  1992-04

3.  Diagnostic and therapeutic technology assessment. Measurement of bone density with dual-energy X-ray absorptiometry (DEXA)

Authors: 
Journal:  JAMA       Date:  1992-01-08       Impact factor: 56.272

4.  Skeletal status in rheumatoid arthritis. A preliminary report.

Authors:  M N Mueller; J M Jurist
Journal:  Arthritis Rheum       Date:  1973 Jan-Feb

5.  Prevention and treatment of osteoporosis.

Authors:  R Lindsay
Journal:  Lancet       Date:  1993-03-27       Impact factor: 79.321

6.  Spinal bone loss and ovulatory disturbances.

Authors:  J C Prior; Y M Vigna; M T Schechter; A E Burgess
Journal:  N Engl J Med       Date:  1990-11-01       Impact factor: 91.245

Review 7.  Biochemical markers of bone turnover for the clinical investigation of osteoporosis.

Authors:  P D Delmas
Journal:  Osteoporos Int       Date:  1993       Impact factor: 4.507

8.  Quantitative computed tomography for prediction of vertebral fracture risk.

Authors:  C E Cann; H K Genant; F O Kolb; B Ettinger
Journal:  Bone       Date:  1985       Impact factor: 4.398

9.  Baseline measurement of bone mass predicts fracture in white women.

Authors:  S L Hui; C W Slemenda; C C Johnston
Journal:  Ann Intern Med       Date:  1989-09-01       Impact factor: 25.391

10.  Total and regional bone mineral content in women treated with GnRH agonists.

Authors:  H Rico; F Arnanz; M Revilla; S Perera; M Iritia; L F Villa; I Arribas
Journal:  Calcif Tissue Int       Date:  1993-05       Impact factor: 4.333

View more
  8 in total

1.  Abnormal bone microarchitecture and evidence of osteoblast dysfunction in premenopausal women with idiopathic osteoporosis.

Authors:  Adi Cohen; David W Dempster; Robert R Recker; Emily M Stein; Joan M Lappe; Hua Zhou; Andreas J Wirth; G Harry van Lenthe; Thomas Kohler; Alexander Zwahlen; Ralph Müller; Clifford J Rosen; Serge Cremers; Thomas L Nickolas; Donald J McMahon; Halley Rogers; Ronald B Staron; Jeanette LeMaster; Elizabeth Shane
Journal:  J Clin Endocrinol Metab       Date:  2011-08-10       Impact factor: 5.958

Review 2.  Premenopausal Osteoporosis.

Authors:  Adi Cohen
Journal:  Endocrinol Metab Clin North Am       Date:  2016-11-24       Impact factor: 4.741

3.  Evaluation and management of the premenopausal woman with low BMD.

Authors:  Adi Cohen; Elizabeth Shane
Journal:  Curr Osteoporos Rep       Date:  2013-12       Impact factor: 5.096

4.  Bone microarchitecture and stiffness in premenopausal women with idiopathic osteoporosis.

Authors:  Adi Cohen; X Sherry Liu; Emily M Stein; Donald J McMahon; Halley F Rogers; Jeanette Lemaster; Robert R Recker; Joan M Lappe; X Edward Guo; Elizabeth Shane
Journal:  J Clin Endocrinol Metab       Date:  2009-10-16       Impact factor: 5.958

5.  Central QCT reveals lower volumetric BMD and stiffness in premenopausal women with idiopathic osteoporosis, regardless of fracture history.

Authors:  Adi Cohen; Thomas F Lang; Donald J McMahon; X Sherry Liu; X Edward Guo; Chiyuan Zhang; Emily M Stein; David W Dempster; Polly Young; Isra Saeed; Joan M Lappe; Robert R Recker; Elizabeth Shane
Journal:  J Clin Endocrinol Metab       Date:  2012-09-07       Impact factor: 5.958

6.  Clinical characteristics and medication use among premenopausal women with osteoporosis and low BMD: the experience of an osteoporosis referral center.

Authors:  Adi Cohen; Jessica Fleischer; Matthew J Freeby; Donald J McMahon; Dinaz Irani; Elizabeth Shane
Journal:  J Womens Health (Larchmt)       Date:  2009 Jan-Feb       Impact factor: 2.681

7.  Idiopathic osteoporosis in premenopausal women.

Authors:  Mishaela R Rubin; Debra H Schussheim; Carolina A M Kulak; Etah S Kurland; Clifford J Rosen; John P Bilezikian; Elizabeth Shane
Journal:  Osteoporos Int       Date:  2004-08-05       Impact factor: 4.507

8.  Bone mineral density evolution in young premenopausal women with idiopathic osteoporosis.

Authors:  Pilar Peris; Ana Monegal; M Angeles Martínez; Concepción Moll; Françesca Pons; Nuria Guañabens
Journal:  Clin Rheumatol       Date:  2006-08-29       Impact factor: 3.650

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.